Le Lézard
Classified in: Health
Subjects: MAV, FVT

Media Advisory - Arthritis Research Public Forum Returns for 13th Year


Top Scientists Reveal Latest in Arthritis Prevention and Treatment at ROAR 2018

VANCOUVER, Sep. 25, 2018 /CNW/ - Leading research scientists will present the latest in arthritis prevention and treatment at Arthritis Research Canada's annual Reaching Out with Arthritis Research public forum on September 29.  

Discover the latest advancements in arthritis research, prevention and treatment at ROAR 2018. (CNW Group/Arthritis Research Canada)

PRESENTERS AND TOPICS

Dr. Mark Harrison: Preventing arthritis: would you if you could?
Dr. Mary De Vera: Arthritis medication & pregnancy: is it safe?
Dr. Nick Bansback: Fork in the road: contemplating surgery
Dr. Michael Hunt: Canes, orthotics & footwear: how do they work?
Dr. Catherine Backman: Moving from "What's the matter?" to "What matters"
Dr. John Esdaile: Arthritis Research Canada: transforming lives through research

EVENT DETAILS:

DATE:

 September 29, 2018



TIME:

 9:30am to 12:30pm



LOCATION:

 Ismaili Centre of Burnaby (4010 Canada Way)

 

MORE ABOUT ROAR 2018: http://www.arthritisresearch.ca/roar
REGISTER
FOR ROAR 2018: https://conta.cc/2MLl7U2

SOURCE Arthritis Research Canada


These press releases may also interest you

at 17:00
LifeSpeak Inc. ("LifeSpeak" or the "Company") , the leading whole-person wellbeing solution for employers, health plans and other organizations, announced today that it will release its first quarter 2024 financial results before market open on...

at 16:59
The Honourable Mark Holland, Minister of Health, will host an event in Oshawa to highlight Budget 2024's investments in Canada's electric vehicle supply chain and the future of Canada's automotive industry. A media availability will follow the...

at 16:56
Hartford HealthCare is among the top 20% of hospitals nationwide recognized for outstanding patient safety ratings and the highest level of adherence to federal price transparency rules....

at 16:40
Pfizer Inc. today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company's common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of business on May 10, 2024. The...

at 16:35
Ecolab will host a live webcast of its annual meeting of stockholders. As indicated in our proxy statement, the 2024 Annual Meeting of Stockholders will be a virtual-only meeting. Details for the public webcast are as follows: TIME:...

at 16:35
Summit Therapeutics Inc. ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens....



News published on and distributed by: